A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

NCT03648788 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-09-06

No results posted yet for this study

Summary

Post-marketing surveillance of Rosuvastatin/Ezetimibe

Conditions

  • Mixed Dyslipidemia

Interventions

OTHER

NA (Observation study)

NA (Observation study)

Sponsors & Collaborators

  • IlDong Pharmaceutical Co Ltd

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2024-06-30
Completion
2024-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648788 on ClinicalTrials.gov